The National Cancer Institute and National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, seek input through May 26 on research priorities for COVID-19 serology testing and related technologies, which are key to understanding immunity and developing vaccines against the virus.

The Paycheck Protection Program and Health Care Enhancement Act provides $306 million to NIH to develop, validate, improve and implement serological testing and associated technologies.

The agency intends to solicit applications for funding to establish Serological Sciences Centers of Excellence and projects to advance research on immune responses to the SARS-CoV-2 virus, including how it relates to cancer patients.

Related News Articles

Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…